Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding the Burden of Coinfection: COVID-19 in Hospitalized Patients with Diagnosed and Undiagnosed Advanced HIV.

Current HIV research·2026
Same author

[Cardio-renal syndrome: perspectives of research in infectious diseases].

Terapevticheskii arkhiv·2026
Same author

Regional, Age, and Sex Patterns of Hepatitis C Virus Infection in Russia: Insights from a 42,000-Participant Serosurvey.

Viruses·2025
Same author

Overcoming Antibiotic Resistance and Treating Bacterial Infections with Biological Nanoparticles.

International journal of molecular sciences·2025
Same author

CAR Therapies: Ex Vivo and In Vivo Potential of Exosomes and Biomimetic Nanoparticles.

Cancers·2025
Same author

In Vivo Behavior of Biomimetic Nanoparticles: Strategies for Clearance Avoidance, Targeting, and Functional Delivery.

Molecules (Basel, Switzerland)·2025

Related Experiment Video

Updated: May 12, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

15.9K

[Infant botulism: an underestimated problem. A review].

V A Malov1, V V Maleev2, V P Chulanov1

  • 1Sechenov First Moscow State Medical University (Sechenov University).

Terapevticheskii Arkhiv
|December 28, 2024
PubMed
Summary
This summary is machine-generated.

Infant botulism, a rare condition, occurs when infants ingest spores that grow in the intestines, producing toxin and causing paralysis. This article details its unique features, diagnosis, and treatment.

Keywords:
Clostridium botulinumbotulisminfant botulism

More Related Videos

Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

18.3K
Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
08:32

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Published on: February 17, 2023

1.2K

Related Experiment Videos

Last Updated: May 12, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

15.9K
Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

18.3K
Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
08:32

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Published on: February 17, 2023

1.2K

Area of Science:

  • Medical Microbiology
  • Pediatric Infectious Diseases
  • Neuroscience

Background:

  • Infant botulism is a rare neuroparalytic illness caused by *Clostridium botulinum* spores.
  • Unlike foodborne botulism, infant botulism involves intestinal spore germination and toxin production *in situ*.
  • This form of botulism is exclusively diagnosed in infants, presenting unique clinical and epidemiological characteristics.

Purpose of the Study:

  • To provide a comprehensive overview of infant botulism, a poorly understood condition in the country.
  • To elucidate the distinct pathogenesis, clinical manifestations, and epidemiological factors of infant botulism.
  • To detail diagnostic methods, laboratory confirmation, and current treatment strategies for infant botulism.

Main Methods:

  • Review of existing literature and case studies on infant botulism.
  • Analysis of epidemiological data and risk factors associated with infant botulism.
  • Synthesis of current diagnostic and therapeutic approaches for infant botulism.

Main Results:

  • Infant botulism pathogenesis involves spore ingestion, intestinal colonization, and *in situ* toxin production, leading to flaccid paralysis.
  • Specific clinical features and epidemiological risk factors differentiate infant botulism from other forms.
  • Established diagnostic criteria and laboratory methods aid in identifying the etiology of infant botulism.

Conclusions:

  • Infant botulism requires specialized understanding due to its unique pathophysiology and clinical presentation.
  • Early diagnosis and appropriate management are crucial for improving outcomes in affected infants.
  • Further research and awareness are necessary to address this life-threatening condition in infants.